Optimising Cryoprotectant Formulations: Comparing Glycerol, DMSO and Ethylene Glycol Performance

How do glycerol, DMSO and ethylene glycol differ in cryoprotectant effectiveness?

Glycerol, dimethyl sulfoxide (DMSO) and ethylene glycol (EG) protect cells by reducing ice crystal formation and stabilising membranes during freezing. Their performance is governed by permeability, toxicity, and the ability to balance intracellular and extracellular osmolarity. Comparative studies show that DMSO typically yields the highest post‑thaw viability for mammalian cell lines, while glycerol is favoured for bacterial and yeast cultures due to lower cytotoxicity. Ethylene glycol, with a smaller molecular size, penetrates cells rapidly and can be advantageous in protocols requiring fast cooling rates.

Find out more about Dimethyl sulfoxide - (DMSO) on our product page →

Find out more about Glycerol on our product page →

What concentrations of glycerol, DMSO and ethylene glycol are recommended for optimal cell survival?

The optimal concentration varies with cell type and cooling regime. For most mammalian suspension cells, 5–10 % (v/v) DMSO is standard, providing viability in the 70–90 % range when combined with a controlled‑rate freezer. Glycerol requires higher concentrations, typically 15–20 % (v/v), to achieve comparable protection, but the increased viscosity can impair handling. Ethylene glycol is effective at 5–15 % (v/v); studies report comparable viabilities to DMSO at the lower end of this range, with the added benefit of reduced osmotic shock during rapid thawing.

How does toxicity influence the choice between glycerol, DMSO and ethylene glycol?

Toxicity is a critical factor, especially for downstream applications such as cell therapy or protein expression. DMSO exhibits dose‑dependent cytotoxicity, with cell death rates increasing markedly above 10 % (v/v) and after prolonged exposure (>30 min) at room temperature. Glycerol is considerably less toxic, allowing longer exposure times, but its high concentration can cause osmotic stress. Ethylene glycol shows intermediate toxicity; it is less harmful than DMSO at equivalent concentrations but more toxic than glycerol. Consequently, protocols often include a rapid dilution step post‑thaw to mitigate DMSO‑induced apoptosis.

Are there synergistic effects when combining glycerol and ethylene glycol?

Yes. A head‑to‑head comparison demonstrated that a mixed cryoprotectant containing 10 % glycerol and 5 % ethylene glycol outperformed either agent alone in terms of post‑thaw recovery for several mammalian cell lines. The mixture leverages glycerol’s low toxicity and ethylene glycol’s rapid permeation, resulting in higher viability and reduced ice recrystallisation. However, the exact ratio must be empirically optimised, as excessive glycerol can increase solution viscosity, while too much ethylene glycol may raise toxicity.

What practical considerations should be taken into account when selecting a cryoprotectant?

1. Cell type – Bacterial and yeast cells tolerate higher glycerol concentrations; mammalian cells often require DMSO or EG.
2. Cooling rate – Slow‑cooling protocols (≤1 °C min⁻¹) benefit from glycerol; rapid cooling (vitrification) favours EG due to its fast permeation.
3. Regulatory constraints – For clinical cell products, DMSO is the most widely accepted, but residual DMSO must be reduced below 0.5 % (v/v) before infusion.
4. Down‑stream processing – If immediate use is required, minimise cryoprotectant removal steps; ethylene glycol’s lower viscosity simplifies washing.
5. Storage temperature – All three agents are suitable for liquid nitrogen storage (‑196 °C), but long‑term stability studies suggest glycerol‑based solutions maintain pH better over years.

Frequently asked questions

Q1: Can I replace DMSO with ethylene glycol in an existing protocol? A: In many cases, yes. Substitute 5–10 % DMSO with an equivalent concentration of ethylene glycol and validate post‑thaw viability, as EG may require slight adjustments to cooling rates.

Q2: How quickly must DMSO‑containing samples be thawed? A: Rapid thawing (37 °C water bath, 1–2 min) is recommended to limit DMSO‑induced toxicity and prevent ice recrystallisation.

Q3: Is glycerol suitable for cryopreserving primary human cells? A: Glycerol is generally less effective for primary human lymphocytes and stem cells, where DMSO or EG provide higher recovery rates.

Q4: What washing steps are needed after thawing? A: For DMSO, dilute the cell suspension in pre‑warmed culture medium and centrifuge within 5 min; for glycerol, a single wash may suffice; ethylene glycol often requires two washes to reduce residual concentration.